Views
1 year ago

2004 Scientific Report

External Collaborators

External Collaborators Milton Gross, Department of Veterans Affairs Medical Center/University of Michigan, Ann Arbor David Wenkert, Michigan State University, East Lansing Beatrice Knudsen, Fred Hutchinson Cancer Research Center, Seattle, Washington David Waters, Gerald P. Murphy Cancer Foundation, Seattle, Washington Wei-cheng You, Beijing Institute for Cancer Research, China Ji-you Li, Beijing Institute for Cancer Research, China Yi Ren, Hong Kong University, China Xiao-hong Guan, Nanjing Medical University, China Zhen-qing Feng, Nanjing Medical University, China Kang-lin Wan, Chinese Centers for Disease Control and Prevention, Beijing Recent Publications Hay, Rick V., Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, Beatrice S. Knudsen, Margaret F. Gustafson, Han-Mo Koo, George F. Vande Woude, and Milton D. Gross. 2003. Radioimmunoscintigraphy of human Met-expressing tumor xenografts using Met3, a new monoclonal antibody. Clinical Cancer Research 9(10): 3839S–3844S. You, Xueke, Hsiao-Man Yu, Leona Cohen-Gould, Brian Cao, Marc Symons, George F. Vande Woude, and Beatrice S. Knudsen. 2003. Regulation of migration of primary prostate epithelial cells by secreted factors from prostate stromal cells. Experimental Cell Research 288(2): 246–256. Hay, Rick, Brian Cao, Ilan Tsarfaty, Galia Tsarfaty, James Resau, and George Vande Woude. 2002. Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use. Journal of Cellular Biochemistry S39: 184–193. From left to right: Gieske, Guo, Jiao, Zhao, Cao 14

Suppression of LSAMP, NORE1A, and Nore1 reexpression Reexpression and localization of EGFP-LASMP, -NORE1A, and -NORE1 fusion protein 2 h after microinjection or 24 h after lipid-mediated transfection of pEGFP-LSAMP, -NORE1A, and -Nore1 plasmids. Green shows the expressed protein; blue, the cell nucleus; and red, microtubules. (Chen, Alberts, and Teh) 15

Publications by Year